Rapid communication Open Access
Like 0


The infrastructure in cities provides unique opportunities to eliminate HIV. Since 2014, the HIV Transmission Elimination AMsterdam Initiative, a consortium involved in HIV prevention and care, has employed an integrated approach to curb HIV incidence in Amsterdam. This effort contributed to the 95% decline in estimated newly acquired infections and the 79% decline in observed new HIV diagnoses in Amsterdam from 2010 to 2022. In 2022, Amsterdam reached and exceeded the 95–95–95 UNAIDS treatment cascade goals (98–95%-96%).


Article metrics loading...

Loading full text...

Full text loading...



  1. United Nations Programme on HIV/AIDS (UNAIDS). The Cities Report. Geneva: UNAIDS; 2014. Available from: http://www.unaids.org/en/resources/documents/2014/thecitiesreport
  2. Fast-Track Cities. London getting to zero. [Accessed: 2 Oct 2023]. Available from: https://fasttrackcities.london
  3. Getting to Zero San Francisco. About HIV and San Francisco. [Accessed: 2 Oct 2023]. Available from: https://gettingtozerosf.org/about-hiv-and-san-francisco
  4. H-TEAM. [Accessed: 2 Oct 2023]. Available from: https://hteam.nl
  5. de Bree GJ, van Sighem A, Zuilhof W, van Bergen JEAM, Prins M, Heidenrijk M, et al. Is reaching 90-90-90 enough to end AIDS? Lessons from Amsterdam. Curr Opin HIV AIDS. 2019;14(6):455-63.  https://doi.org/10.1097/COH.0000000000000586  PMID: 31589173 
  6. Boender TS, Smit C, Sighem AV, Bezemer D, Ester CJ, Zaheri S, et al. AIDS Therapy Evaluation in the Netherlands (ATHENA) national observational HIV cohort: cohort profile. BMJ Open. 2018;8(9):e022516.  https://doi.org/10.1136/bmjopen-2018-022516  PMID: 30249631 
  7. Blenkinsop A, Monod M, van Sighem A, Pantazis N, Bezemer D, Op de Coul E, et al. Estimating the potential to prevent locally acquired HIV infections in a UNAIDS Fast-Track City, Amsterdam. eLife. 2022;11:e76487.  https://doi.org/10.7554/eLife.76487  PMID: 35920649 
  8. European Centre for Disease Prevention and Control (ECDC). HIV Platform tool. Stockholm: ECDC; 2021. Available from: https://www.ecdc.europa.eu/en/publications-data/hiv-platform-tool
  9. van Sighem AI, Wit FWNM, Boyd A, Smit C, Matser A, van der Valk M, et al. HIV monitoring report 2022. Human Immunodeficiency Virus (HIV) Infection in the Netherlands. Amsterdam: Stichting HIV Monitoring; 2022. Available from: https://www.hiv-monitoring.nl/en/resources/monitoring-report-2022
  10. Bogers S, Nieuwkerk P, van Dijk N, Schim van der Loeff M, Geerlings S, van Bergen J, et al. Understanding the effect of an educational intervention to optimize HIV testing strategies in primary care in Amsterdam - results of a mixed-methods study. BMC Prim Care. 2023;24(1):201.  https://doi.org/10.1186/s12875-023-02161-y  PMID: 37777732 
  11. Jones A, Cremin I, Abdullah F, Idoko J, Cherutich P, Kilonzo N, et al. Transformation of HIV from pandemic to low-endemic levels: a public health approach to combination prevention. Lancet. 2014;384(9939):272-9.  https://doi.org/10.1016/S0140-6736(13)62230-8  PMID: 24740087 
  12. Hoornenborg E, Coyer L, Achterbergh RCA, Matser A, Schim van der Loeff MF, Boyd A, et al. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study. Lancet HIV. 2019;6(7):e447-55.  https://doi.org/10.1016/S2352-3018(19)30136-5  PMID: 31178284 
  13. McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53-60.  https://doi.org/10.1016/S0140-6736(15)00056-2  PMID: 26364263 
  14. Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237-46.  https://doi.org/10.1056/NEJMoa1506273  PMID: 26624850 
  15. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20(10):1447-50.  https://doi.org/10.1097/01.aids.0000233579.79714.8d  PMID: 16791020 
  16. Ratmann O, van Sighem A, Bezemer D, Gavryushkina A, Jurriaans S, Wensing A, et al. Sources of HIV infection among men having sex with men and implications for prevention. Sci Transl Med. 2016;8(320):320ra2.  https://doi.org/10.1126/scitranslmed.aad1863  PMID: 26738795 
  17. H-TEAM. Heb ik HIV? [Do I have HIV?]. [Accessed: 2 Oct 2023]. Available from: https://hebikhiv.nl/en
  18. Dijkstra M, de Bree GJ, Stolte IG, Davidovich U, Sanders EJ, Prins M, et al. Development and validation of a risk score to assist screening for acute HIV-1 infection among men who have sex with men. BMC Infect Dis. 2017;17(1):425.  https://doi.org/10.1186/s12879-017-2508-4  PMID: 28615005 
  19. Dijkstra M, van Rooijen MS, Hillebregt MM, van Sighem A, Smit C, Hogewoning A, et al. Decreased time to viral suppression after implementation of targeted testing and immediate initiation of treatment of acute HIV infection among men who have sex with men in Amsterdam. Clin Infect Dis. 2020;72(11):1952-60.  https://doi.org/10.1093/cid/ciaa505  PMID: 32369099 
  20. HIV in Europe. HIV indicator conditions: Guidance for implementing HIV testing in adults in health care settings. Copenhagen: HIV in Europe Secretariat; 2012. Available from: https://www.eurotest.org/media/0ymdzdvu/guidancepdf.pdf
  21. Bogers SJ, Hulstein SH, Schim van der Loeff MF, de Bree GJ, Reiss P, van Bergen JEAM, et al. Current evidence on the adoption of indicator condition guided testing for HIV in western countries: A systematic review and meta-analysis. EClinicalMedicine. 2021;35:100877.  https://doi.org/10.1016/j.eclinm.2021.100877  PMID: 34027336 
  22. Bogers SJ, Schim van der Loeff MF, Boyd A, Davidovich U, van der Valk M, Brinkman K, et al. Improving indicator-condition guided testing for HIV in the hospital setting (PROTEST 2·0): A multicenter, interrupted time-series analysis. Lancet Reg Health Eur. 2022;23:100515.  https://doi.org/10.1016/j.lanepe.2022.100515  PMID: 36246146 
  23. Gemeente Amsterdam. Hiv naar nul. [HIV to zero]. Amsterdam: GGD Amsterdam. [Accessed: 3 Oct 2023]. Dutch. Available from: https://www.ggd.amsterdam.nl/infectieziekten/hiv-nul

Data & Media loading...

Submit comment
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error